Literature DB >> 2025128

Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome.

P Muńoz, S Moreno, J Berenguer, J C Bernaldo de Quirós, E Bouza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2025128     DOI： 10.1001/archinte.1991.00400050150032

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  5 in total

1.  A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs.

Authors:  L A García Rodríguez; A Duque; J Castellsague; S Pérez-Gutthann; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  1999-12       Impact factor: 4.335

2.  Safety and tolerability of fluconazole in children.

Authors:  V Novelli; H Holzel
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

Review 3.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

Review 4.  Treatment and prophylaxis of invasive candidiasis.

Authors:  Nidhi Tripathi; Kevin Watt; Daniel K Benjamin
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

Review 5.  Updated Perspectives on the Diagnosis and Management of Onychomycosis.

Authors:  Julianne M Falotico; Shari R Lipner
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.